Braidwell portfolio · 2024-09-30
Disclosed long book
$2.32 billion
Long positions
81
Calls / puts
0 / 0
Top 5 concentration
22.3%
Longs with AI data
1 / 81
Average AI 1Y
+14.0%
13F filing comparison
Quarter-over-quarter changes
2024-06-30 to 2024-09-30
Newly reported
16
No longer reported
10
Increased
26
Reduced
24
Newly reported this quarter
Present now and absent from the immediately preceding comparable filing.
| Position | Kind | Shares | Value |
|---|---|---|---|
EDGEWISE THERAPEUTICS INC EDGEWISE THERAPEUTICS INC | LONG | 1,958,310 | $52.3 million |
BICARA THERAPEUTICS INC BICARA THERAPEUTICS INC | LONG | 1,657,600 | $42.2 million |
MADRIGAL PHARMACEUTICALS INC MADRIGAL PHARMACEUTICALS INC | LONG | 183,818 | $39.0 million |
DEXCOM INC DEXCOM INC | LONG | 441,086 | $29.6 million |
BNTX BIONTECH SE | LONG | 247,750 | $29.4 million |
AMPHASTAR PHARMACEUTICALS IN AMPHASTAR PHARMACEUTICALS IN | LONG | 18,400,000 | $19.5 million |
IMMATICS N.V IMMATICS N.V | LONG | 1,647,565 | $18.8 million |
BSX BOSTON SCIENTIFIC CORP | LONG | 189,200 | $15.9 million |
ORUKA THERAPEUTICS INC ORUKA THERAPEUTICS INC | LONG | 515,726 | $12.6 million |
ZURA BIO LTD ZURA BIO LTD | LONG | 2,472,806 | $10.0 million |
INSULET CORP INSULET CORP | LONG | 42,500 | $9.9 million |
XENCOR INC XENCOR INC | LONG | 466,448 | $9.4 million |
JASPER THERAPEUTICS INC JASPER THERAPEUTICS INC | LONG | 483,300 | $9.1 million |
FULCRUM THERAPEUTICS INC FULCRUM THERAPEUTICS INC | LONG | 1,069,158 | $3.8 million |
VERVE THERAPEUTICS INC VERVE THERAPEUTICS INC | LONG | 623,980 | $3.0 million |
HILLEVAX INC HILLEVAX INC | LONG | 1,064,000 | $1.9 million |
No longer reported this quarter
Present in the prior comparable filing and absent from this one.
| Position | Kind | Prior shares | Prior value |
|---|---|---|---|
89BIO INC 89BIO INC · COM | LONG | 164,227 | $1.3 million |
AKERO THERAPEUTICS INC AKERO THERAPEUTICS INC · COM | LONG | 1,084,400 | $25.4 million |
IMMUNOCORE HLDGS PLC IMMUNOCORE HLDGS PLC · ADS | LONG | 797,268 | $27.0 million |
CONMED CORP CONMED CORP · NOTE 2.250% 6/1 | LONG | 5,000,000 | $4.5 million |
LIVANOVA PLC LIVANOVA PLC · SHS | LONG | 173,900 | $9.5 million |
LONGBOARD PHARMACEUTICALS IN LONGBOARD PHARMACEUTICALS IN · COM | LONG | 205,926 | $5.6 million |
OUTSET MED INC OUTSET MED INC · COM | LONG | 694,525 | $2.7 million |
SAREPTA THERAPEUTICS INC SAREPTA THERAPEUTICS INC · NOTE 1.250% 9/1 | LONG | 43,066,000 | $55.5 million |
THERMO FISHER SCIENTIFIC INC THERMO FISHER SCIENTIFIC INC · COM | LONG | 70,449 | $39.0 million |
TRANSMEDICS GROUP INC TRANSMEDICS GROUP INC · COM | LONG | 189,960 | $28.6 million |
“No longer reported” means the position is absent from this comparable 13F filing. It does not prove the manager sold it: reporting thresholds, confidential treatment, corporate actions, or instrument changes can also explain the omission.
| Position | Kind | Shares | Value | Long weight | Quarter change | AI at filing · 1Y | AI now |
|---|---|---|---|---|---|---|---|
GUARDANT HEALTH INC GUARDANT HEALTH INC · NOTE11/1 · 40131MAB5 | LONG | 268,252,000 | $216.0 million | — | UNCHANGED | — | 1Y — 5Y — |
BRIDGEBIO PHARMA INC BRIDGEBIO PHARMA INC · NOTE 2.500% 3/1 · 10806XAB8 | LONG | 140,838,000 | $145.6 million | — | UNCHANGED | — | 1Y — 5Y — |
NOVOCURE LTD NOVOCURE LTD · NOTE11/0 · 67011XAB9 | LONG | 140,834,000 | $133.3 million | — | UNCHANGED | — | 1Y — 5Y — |
CG ONCOLOGY INC CG ONCOLOGY INC · COM · 156944100 | LONG | 3,170,875 | $119.6 million | 5.2% | REDUCED | — | 1Y — 5Y — |
NUVASIVE INC NUVASIVE INC · NOTE 0.375% 3/1 · 670704AJ4 | LONG | 114,206,000 | $111.9 million | — | UNCHANGED | — | 1Y — 5Y — |
XENON PHARMACEUTICALS INC XENON PHARMACEUTICALS INC · COM · 98420N105 | LONG | 2,707,255 | $106.6 million | 4.6% | INCREASED | — | 1Y — 5Y — |
NEUROCRINE BIOSCIENCES INC NEUROCRINE BIOSCIENCES INC · COM · 64125C109 | LONG | 917,674 | $105.7 million | 4.6% | INCREASED | — | 1Y — 5Y — |
NEOGENOMICS INC NEOGENOMICS INC · NOTE 0.250% 1/1 · 64049MAB6 | LONG | 116,381,000 | $96.9 million | — | UNCHANGED | — | 1Y — 5Y — |
APOGEE THERAPEUTICS INC APOGEE THERAPEUTICS INC · COM · 03770N101 | LONG | 1,643,226 | $96.5 million | 4.2% | REDUCED | — | 1Y — 5Y — |
APELLIS PHARMACEUTICALS INC APELLIS PHARMACEUTICALS INC · COM · 03753U106 | LONG | 3,125,183 | $90.1 million | 3.9% | INCREASED | — | 1Y — 5Y — |
IRONWOOD PHARMACEUTICALS INC IRONWOOD PHARMACEUTICALS INC · NOTE 1.500% 6/1 · 46333XAH1 | LONG | 92,740,000 | $82.5 million | — | INCREASED | — | 1Y — 5Y — |
DEXCOM INC DEXCOM INC · NOTE 0.375% 5/1 · 252131AM9 | LONG | 92,700,000 | $82.3 million | — | INCREASED | — | 1Y — 5Y — |
ALIGN TECHNOLOGY INC ALIGN TECHNOLOGY INC · COM · 016255101 | LONG | 311,679 | $79.3 million | 3.4% | INCREASED | — | 1Y — 5Y — |
GUARDANT HEALTH INC GUARDANT HEALTH INC · COM · 40131M109 | LONG | 3,342,124 | $76.7 million | 3.3% | INCREASED | — | 1Y — 5Y — |
INSULET CORP INSULET CORP · NOTE 0.375% 9/0 · 45784PAK7 | LONG | 63,800,000 | $76.4 million | — | REDUCED | — | 1Y — 5Y — |
LEGEND BIOTECH CORP LEGEND BIOTECH CORP · SPONSORED ADS · 52490G102 | LONG | 1,541,551 | $75.1 million | 3.2% | REDUCED | — | 1Y — 5Y — |
VIKING THERAPEUTICS INC VIKING THERAPEUTICS INC · COM · 92686J106 | LONG | 1,156,977 | $73.2 million | 3.2% | INCREASED | — | 1Y — 5Y — |
KINIKSA PHARMACEUTICALS INTL KINIKSA PHARMACEUTICALS INTL · ORD SHS CL A · G52694109 | LONG | 2,894,513 | $72.3 million | 3.1% | INCREASED | — | 1Y — 5Y — |
PENUMBRA INC PENUMBRA INC · COM · 70975L107 | LONG | 361,428 | $70.2 million | 3.0% | INCREASED | — | 1Y — 5Y — |
DEXCOM INC DEXCOM INC · NOTE 0.250%11/1 · 252131AK3 | LONG | 73,500,000 | $70.1 million | — | UNCHANGED | — | 1Y — 5Y — |
MARAVAI LIFESCIENCES HLDGS I MARAVAI LIFESCIENCES HLDGS I · COM CL A · 56600D107 | LONG | 8,353,287 | $69.4 million | 3.0% | REDUCED | — | 1Y — 5Y — |
DAY ONE BIOPHARMACEUTICALS I DAY ONE BIOPHARMACEUTICALS I · COM · 23954D109 | LONG | 4,873,853 | $67.9 million | 2.9% | INCREASED | — | 1Y — 5Y — |
SPYRE THERAPEUTICS INC SPYRE THERAPEUTICS INC · COM NEW · 00773J202 | LONG | 2,189,836 | $64.4 million | 2.8% | REDUCED | — | 1Y — 5Y — |
REPLIGEN CORP REPLIGEN CORP · COM · 759916109 | LONG | 396,781 | $59.0 million | 2.5% | INCREASED | — | 1Y — 5Y — |
IRHYTHM HOLDINGS INC IRHYTHM HOLDINGS INC · COM · 450056106 | LONG | 782,557 | $58.1 million | 2.5% | INCREASED | — | 1Y — 5Y — |
TRAVERE THERAPEUTICS INC TRAVERE THERAPEUTICS INC · NOTE 2.500% 9/1 · 761299AB2 | LONG | 56,031,000 | $53.5 million | — | UNCHANGED | — | 1Y — 5Y — |
ALPHATEC HLDGS INC ALPHATEC HLDGS INC · NOTE 0.750% 8/0 · 02081GAB8 | LONG | 58,217,000 | $52.5 million | — | UNCHANGED | — | 1Y — 5Y — |
ARGENX SE ARGENX SE · SPONSORED ADR · 04016X101 | LONG | 96,724 | $52.4 million | 2.3% | REDUCED | — | 1Y — 5Y — |
EDGEWISE THERAPEUTICS INC EDGEWISE THERAPEUTICS INC · COM · 28036F105 | LONG | 1,958,310 | $52.3 million | 2.3% | NEWLY REPORTED | — | 1Y — 5Y — |
INSPIRE MED SYS INC INSPIRE MED SYS INC · COM · 457730109 | LONG | 238,911 | $50.4 million | 2.2% | REDUCED | — | 1Y — 5Y — |
SAREPTA THERAPEUTICS INC SAREPTA THERAPEUTICS INC · COM · 803607100 | LONG | 370,400 | $46.3 million | 2.0% | INCREASED | — | 1Y — 5Y — |
BRIDGEBIO PHARMA INC BRIDGEBIO PHARMA INC · NOTE 2.250% 2/0 · 10806XAD4 | LONG | 53,594,000 | $45.0 million | — | REDUCED | — | 1Y — 5Y — |
INTUITIVE SURGICAL INC INTUITIVE SURGICAL INC · COM NEW · 46120E602 | LONG | 91,300 | $44.9 million | 1.9% | REDUCED | — | 1Y — 5Y — |
AVADEL PHARMACEUTICALS PLC AVADEL PHARMACEUTICALS PLC · COM SHS · G29687103 | LONG | 3,388,939 | $44.4 million | 1.9% | INCREASED | — | 1Y — 5Y — |
BICARA THERAPEUTICS INC BICARA THERAPEUTICS INC · COM · 055477103 | LONG | 1,657,600 | $42.2 million | 1.8% | NEWLY REPORTED | — | 1Y — 5Y — |
KEROS THERAPEUTICS INC KEROS THERAPEUTICS INC · COM · 492327101 | LONG | 707,240 | $41.1 million | 1.8% | REDUCED | — | 1Y — 5Y — |
GLAUKOS CORP GLAUKOS CORP · COM · 377322102 | LONG | 311,616 | $40.6 million | 1.7% | REDUCED | — | 1Y — 5Y — |
MADRIGAL PHARMACEUTICALS INC MADRIGAL PHARMACEUTICALS INC · COM · 558868105 | LONG | 183,818 | $39.0 million | 1.7% | NEWLY REPORTED | — | 1Y — 5Y — |
VAXCYTE INC VAXCYTE INC · COM · 92243G108 | LONG | 297,568 | $34.0 million | 1.5% | REDUCED | — | 1Y — 5Y — |
REPLIMUNE GROUP INC REPLIMUNE GROUP INC · COM · 76029N106 | LONG | 3,070,837 | $33.7 million | 1.4% | INCREASED | — | 1Y — 5Y — |
ARVINAS INC ARVINAS INC · COM · 04335A105 | LONG | 1,284,472 | $31.6 million | 1.4% | INCREASED | — | 1Y — 5Y — |
KRYSTAL BIOTECH INC KRYSTAL BIOTECH INC · COM · 501147102 | LONG | 168,691 | $30.7 million | 1.3% | INCREASED | — | 1Y — 5Y — |
ORTHOPEDIATRICS CORP ORTHOPEDIATRICS CORP · COM · 68752L100 | LONG | 1,107,770 | $30.0 million | 1.3% | UNCHANGED | — | 1Y — 5Y — |
DEXCOM INC DEXCOM INC · COM · 252131107 | LONG | 441,086 | $29.6 million | 1.3% | NEWLY REPORTED | — | 1Y — 5Y — |
BNTX BioNTech SE | LONG | 247,750 | $29.4 million | 1.3% | NEWLY REPORTED | — | 1Y +14.0% 5Y +101.1% · 23 models |
PARAGON 28 INC PARAGON 28 INC · COM · 69913P105 | LONG | 4,135,109 | $27.6 million | 1.2% | REDUCED | — | 1Y — 5Y — |
RELAY THERAPEUTICS INC RELAY THERAPEUTICS INC · COM · 75943R102 | LONG | 3,499,427 | $24.8 million | 1.1% | INCREASED | — | 1Y — 5Y — |
ALPHATEC HLDGS INC ALPHATEC HLDGS INC · COM NEW · 02081G201 | LONG | 4,041,065 | $22.5 million | 1.0% | INCREASED | — | 1Y — 5Y — |
HARROW INC HARROW INC · COM · 415858109 | LONG | 439,638 | $19.8 million | 0.9% | INCREASED | — | 1Y — 5Y — |
CULLINAN THERAPEUTICS INC CULLINAN THERAPEUTICS INC · COM · 230031106 | LONG | 1,176,173 | $19.7 million | 0.8% | INCREASED | — | 1Y — 5Y — |
AMPHASTAR PHARMACEUTICALS IN AMPHASTAR PHARMACEUTICALS IN · NOTE 2.000% 3/1 · 03209RAB9 | LONG | 18,400,000 | $19.5 million | — | NEWLY REPORTED | — | 1Y — 5Y — |
EXACT SCIENCES CORP EXACT SCIENCES CORP · COM · 30063P105 | LONG | 286,178 | $19.5 million | 0.8% | REDUCED | — | 1Y — 5Y — |
OCULAR THERAPEUTIX INC OCULAR THERAPEUTIX INC · COM · 67576A100 | LONG | 2,239,770 | $19.5 million | 0.8% | INCREASED | — | 1Y — 5Y — |
IMMATICS N.V IMMATICS N.V · SHS · N44445109 | LONG | 1,647,565 | $18.8 million | 0.8% | NEWLY REPORTED | — | 1Y — 5Y — |
IRONWOOD PHARMACEUTICALS INC IRONWOOD PHARMACEUTICALS INC · COM CL A · 46333X108 | LONG | 4,438,232 | $18.3 million | 0.8% | UNCHANGED | — | 1Y — 5Y — |
BSX Boston Scientific | LONG | 189,200 | $15.9 million | 0.7% | NEWLY REPORTED | — | 1Y — 5Y — |
DIANTHUS THERAPEUTICS INC DIANTHUS THERAPEUTICS INC · COM · 252828108 | LONG | 493,687 | $13.5 million | 0.6% | INCREASED | — | 1Y — 5Y — |
4D MOLECULAR THERAPEUTICS IN 4D MOLECULAR THERAPEUTICS IN · COM · 35104E100 | LONG | 1,225,448 | $13.2 million | 0.6% | INCREASED | — | 1Y — 5Y — |
CELCUITY INC CELCUITY INC · COM · 15102K100 | LONG | 884,306 | $13.2 million | 0.6% | INCREASED | — | 1Y — 5Y — |
ORUKA THERAPEUTICS INC ORUKA THERAPEUTICS INC · COM · 687604108 | LONG | 515,726 | $12.6 million | 0.5% | NEWLY REPORTED | — | 1Y — 5Y — |
HAEMONETICS CORP MASS HAEMONETICS CORP MASS · NOTE3/0 · 405024AB6 | LONG | 11,500,000 | $10.6 million | — | UNCHANGED | — | 1Y — 5Y — |
ALECTOR INC ALECTOR INC · COM · 014442107 | LONG | 2,158,245 | $10.1 million | 0.4% | REDUCED | — | 1Y — 5Y — |
ZURA BIO LTD ZURA BIO LTD · CLASS A ORD SHS · G9TY5A101 | LONG | 2,472,806 | $10.0 million | 0.4% | NEWLY REPORTED | — | 1Y — 5Y — |
INSULET CORP INSULET CORP · COM · 45784P101 | LONG | 42,500 | $9.9 million | 0.4% | NEWLY REPORTED | — | 1Y — 5Y — |
NEVRO CORP NEVRO CORP · COM · 64157F103 | LONG | 1,698,768 | $9.5 million | 0.4% | UNCHANGED | — | 1Y — 5Y — |
CASTLE BIOSCIENCES INC CASTLE BIOSCIENCES INC · COM · 14843C105 | LONG | 331,986 | $9.5 million | 0.4% | REDUCED | — | 1Y — 5Y — |
XENCOR INC XENCOR INC · COM · 98401F105 | LONG | 466,448 | $9.4 million | 0.4% | NEWLY REPORTED | — | 1Y — 5Y — |
JASPER THERAPEUTICS INC JASPER THERAPEUTICS INC · COM NEW · 471871202 | LONG | 483,300 | $9.1 million | 0.4% | NEWLY REPORTED | — | 1Y — 5Y — |
BRIDGEBIO PHARMA INC BRIDGEBIO PHARMA INC · COM · 10806X102 | LONG | 298,400 | $7.6 million | 0.3% | REDUCED | — | 1Y — 5Y — |
LEXEO THERAPEUTICS INC LEXEO THERAPEUTICS INC · COM · 52886X107 | LONG | 728,777 | $6.6 million | 0.3% | REDUCED | — | 1Y — 5Y — |
PULMONX CORP PULMONX CORP · COM · 745848101 | LONG | 752,541 | $6.2 million | 0.3% | UNCHANGED | — | 1Y — 5Y — |
THE BEAUTY HEALTH COMPANY THE BEAUTY HEALTH COMPANY · COM CL A · 88331L108 | LONG | 4,049,694 | $5.8 million | 0.3% | REDUCED | — | 1Y — 5Y — |
CUTERA INC CUTERA INC · NOTE 4.000% 6/0 · 232109AG3 | LONG | 29,000,000 | $5.0 million | — | UNCHANGED | — | 1Y — 5Y — |
CUTERA INC CUTERA INC · NOTE 2.250% 6/0 · 232109AD0 | LONG | 25,240,000 | $4.0 million | — | UNCHANGED | — | 1Y — 5Y — |
FULCRUM THERAPEUTICS INC FULCRUM THERAPEUTICS INC · COM · 359616109 | LONG | 1,069,158 | $3.8 million | 0.2% | NEWLY REPORTED | — | 1Y — 5Y — |
VERVE THERAPEUTICS INC VERVE THERAPEUTICS INC · COM · 92539P101 | LONG | 623,980 | $3.0 million | 0.1% | NEWLY REPORTED | — | 1Y — 5Y — |
IOVANCE BIOTHERAPEUTICS INC IOVANCE BIOTHERAPEUTICS INC · COM · 462260100 | LONG | 217,928 | $2.0 million | 0.1% | REDUCED | — | 1Y — 5Y — |
HILLEVAX INC HILLEVAX INC · COM · 43157M102 | LONG | 1,064,000 | $1.9 million | 0.1% | NEWLY REPORTED | — | 1Y — 5Y — |
LEXICON PHARMACEUTICALS INC LEXICON PHARMACEUTICALS INC · COM NEW · 528872302 | LONG | 801,584 | $1.3 million | 0.1% | REDUCED | — | 1Y — 5Y — |
DBV TECHNOLOGIES S A DBV TECHNOLOGIES S A · SPONSORED ADR · 23306J200 | LONG | 1,630,542 | $1.1 million | 0.0% | REDUCED | — | 1Y — 5Y — |
ELEVATION ONCOLOGY INC ELEVATION ONCOLOGY INC · COM · 28623U101 | LONG | 473,503 | $284,054 | 0.0% | REDUCED | — | 1Y — 5Y — |